Second Primary Malignancies (SPMs) in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With the Combination of a Targeted Agent With an Antibody in 4 Phase 2 Trials of the German CLL Study Group (GCLLSG)

Autor: Goergen, Ellinor, Tresckow, Julia v., Giza, Adam, Robrecht, Sandra, Fink, Anna-Maria, Fischer, Kirsten, Al-Sawaf, Othman, Fürstenau, Moritz, Simon, Florian, Kutsch, Nadine, Nieper, Pascal, Tausch, Eugen, Ritgen, Matthias, Böttcher, Sebastian, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Langerbeins, Petra, Eichhorst, Barbara, Hallek, Michael, Cramer, Paula
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S182-S182
Databáze: ScienceDirect
Externí odkaz: